Advanced in Asthma in Children

Dr. Muqdad A. Zuriqat

Pulmonary Medicine
403 N Highland Ave, 
Sherman, TX 
Accepting New Patients
Advanced in Asthma in Children
403 N Highland Ave, 
Sherman, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Muqdad Zuriqat is a Pulmonary Medicine provider in Sherman, Texas. Dr. Zuriqat is rated as an Advanced provider by MediFind in the treatment of Asthma in Children. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, Pneumonia, Atypical Pneumonia, and Advanced Bronchoscopy. Dr. Zuriqat is currently accepting new patients.

His clinical research consists of participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pulmonary Medicine
Licenses
Specialist in TX
Hospital Affiliations
Baylor Scott And White Surgical Hospital At Sherma
Wilson N Jones Regional Medical Center
Alliancehealth Durant
Tmc- Bonham Hospital
Texoma Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Baylor Scott & White Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Community Health
  • EPO
  • HMO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
MercyCare
  • EPO
  • HMO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 18 Less Insurance Carriers -

Locations

403 N Highland Ave, Sherman, TX 75092

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Multi-center, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of Mepolizumab 100 mg SC as add-on Treatment in Participants With COPD Experiencing Frequent Exacerbations and Characterized by Eosinophil Levels (Study 208657)
A Multi-center, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of Mepolizumab 100 mg SC as add-on Treatment in Participants With COPD Experiencing Frequent Exacerbations and Characterized by Eosinophil Levels (Study 208657)
Enrollment Status: Completed
Publish Date: August 15, 2025
Intervention Type: Drug, Biological
Study Drug: Mepolizumab
Study Phase: Phase 3
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks (With a 48-week Safety Subset) in Subjects With Moderate to Severe COPD
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks (With a 48-week Safety Subset) in Subjects With Moderate to Severe COPD
Enrollment Status: Completed
Publish Date: November 13, 2023
Intervention Type: Drug
Study Drug: Ensifentrine
Study Phase: Phase 3
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Enrollment Status: Completed
Publish Date: October 16, 2023
Intervention Type: Drug
Study Drug: Ensifentrine
Study Phase: Phase 3
View 2 Less Clinical Trials
Similar Doctors
Distinguished in Asthma in Children
Dr. Shahrukh A. Kureishy
Pulmonary Medicine
Distinguished in Asthma in Children
Dr. Shahrukh A. Kureishy
Pulmonary Medicine

Metroplex Pulmonary And Sleep Center, P.A.

1701 Eldorado Pkwy, Suite 250, 
Mckinney, TX 
 (32.1 miles away)
972-838-1892
Languages Spoken:
English, Hindi, Spanish, Urdu
See accepted insurances
Accepting New Patients
Offers Telehealth

Shahrukh Kureishy is a Pulmonary Medicine provider in Mckinney, Texas. Dr. Kureishy is rated as a Distinguished provider by MediFind in the treatment of Asthma in Children. His top areas of expertise are Lung Metastases, Obstructive Sleep Apnea, Chronic Obstructive Pulmonary Disease (COPD), and Asthma in Children. Dr. Kureishy is currently accepting new patients.

Distinguished in Asthma in Children
Dr. Mark Millard
Pulmonary Medicine | Internal Medicine
Distinguished in Asthma in Children
Dr. Mark Millard
Pulmonary Medicine | Internal Medicine

Baylor Scott & White Advanced Lung Disease Specialists Dallas

3410 Worth St, Ste 250, 
Dallas, TX 
 (59.4 miles away)
972-449-0540
Experience:
49+ years
Languages Spoken:
English
See accepted insurances

Mark Millard is an Internal Medicine specialist and a Pulmonary Medicine provider in Dallas, Texas. Dr. Millard has been practicing medicine for over 49 years and is rated as a Distinguished provider by MediFind in the treatment of Asthma in Children. His top areas of expertise are Asthma, Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, Asthma in Children, and Endoscopy.

Advanced in Asthma in Children
Dr. Carlos Kummerfeldt
Pulmonary Medicine | Intensive Care Medicine
Advanced in Asthma in Children
Dr. Carlos Kummerfeldt
Pulmonary Medicine | Intensive Care Medicine

Healthtexas Provider Network

4001 Worth St, 
Dallas, TX 
 (59.1 miles away)
Experience:
19+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Carlos Kummerfeldt is an Intensive Care Medicine specialist and a Pulmonary Medicine provider in Dallas, Texas. Dr. Kummerfeldt has been practicing medicine for over 19 years and is rated as a Distinguished provider by MediFind in the treatment of Asthma in Children. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, Lung Nodules, Advanced Bronchoscopy, and Gastrostomy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Zuriqat's expertise for a condition
ConditionClose
    View All 10 Advanced Conditions
    View All 32 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile